.png){kind=icon}
返回
J
Jason A. Efstathiou
Barbara Ann Karmanos Cancer Institute
67H指数
657论文数
2.1W被引数
收录论文 291
发表时间
.png){kind=icon}
Development and Validation of a Multimodal Artificial Intelligence–derived Digital Pathology–based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials基于NRG/RTOG试验中根治性前列腺切除术后生化复发患者，开发并验证一种多模态人工智能衍生数字病理学标志物，以预测转移。.png)
European Urology.png)
OAAI
European UrologyIF25.2
OAAI.png){kind=icon}
分享.png){kind=icon}
收藏Multiparametric Magnetic Resonance Imaging and Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnosis and Staging: A Guide for Clinicians from the American College of Radiology VI-RADS Steering Committee多参数磁共振成像和膀胱成像报告与数据系统（VI-RADS）在膀胱癌诊断与分期中的应用：美国放射学院VI-RADS指导委员会为临床医师提供的指南European UrologyOAAI
European UrologyIF25.2
OAAI分享收藏Proceedings of the 2024 National Association for Proton Therapy, Proton Collaborative Group, and Particle Therapy Co-operative Group—North America Proton Therapy Research Forum: Refining Particle Therapy Trial Design and Identifying High-need Areas for Continued Investigation2024年全国质子治疗协会、质子协作组和粒子治疗协作组—北美洲质子治疗研究论坛会议录：优化粒子治疗试验设计并确定需要持续研究的重点领域
PREAI
分享收藏Phase III trial of dose escalated radiation therapy and standard androgen deprivation therapy (ADT) vs. dose escalated radiation therapy and enhanced ADT with orteronel for men with high-risk prostate cancer (NRG/RTOG 1115)剂量 escalated 放射治疗和标准雄激素剥夺治疗（ADT）与剂量 escalated 放射治疗和奥曲酮增强雄激素剥夺治疗的高危前列腺癌患者的III期试验（NRG/RTOG 1115）
PREAI
分享收藏Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial局部高危前列腺癌的转录组学分析改善了预后判断，并确定了在NRG肿瘤学/RTOG 0521 III期试验中，将多西他赛添加到根治性放疗联合雄激素抑制治疗中获益。OAAI
OAAI分享收藏